The Efficacy of Tranexamic Acid in Total Hip Arthroplasty: A Network Meta-analysis

Journal of Arthroplasty

Volumn 33, Issue 10, 2018, Pages 3083-3089.e4

  Fillingham, Yale A ^a   Ramkumar, Dipak B ^b   Jevsevar, David S ^b   Yates, Adolph J ^c   Shores, Peter ^d   Mullen, Kyle ^d   Bini, Stefano A ^e   Clarke, Henry D ^f   Schemitsch, Emil ^g   Johnson, Rebecca L ^h   Memtsoudis, Stavros G ⁱ   Sayeed, Siraj A ^j   Sah, Alexander P ^k   Della Valle, Craig J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d American Academy of Orthopaedic Surgeons   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

^h MAYO CLINIC   (United States)

ⁱ HOSPITAL FOR SPECIAL SURGERY   (United States)

^j South Texas Bone and Joint Institute   (United States)

^k Dearborn Sah Institute for Joint Restoration   (United States)

more..

Author keywords

antifibrinolytic; blood loss; total hip arthroplasty; tranexamic acid; transfusion

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ARTICLE; BLOOD TRANSFUSION; DRUG FORMULATION; HUMAN; INTRAOPERATIVE PERIOD; OPERATIVE BLOOD LOSS; PRACTICE GUIDELINE; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; RISK FACTOR; SYSTEMATIC REVIEW; TOTAL KNEE ARTHROPLASTY; HIP REPLACEMENT; META ANALYSIS; NETWORK META-ANALYSIS; TREATMENT OUTCOME;

ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; NETWORK META-ANALYSIS; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 85049727087     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2018.06.023     Document Type: Article

References (48)

1. Registry, A.J.R., American joint replacement registry annual report 2017. 2017, American Joint Replacement Registry http://www.ajrr.net/images/annual_reports/AJRR-2017-Annual-Report—Final.pdf?hsCtaTracking=61a2fedc-0f48-4241-a282-2bca6e4b68ad%7Ce4ed88d8-6b8e-4d0c-9a47-d1c169759e83.
2. Carling, M.S., Jeppsson, A., Eriksson, B.I., Brisby, H., Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res, 10, 2015, 48.
3. Carson, J.L., Duff, A., Poses, R.M., Berlin, J.A., Spence, R.K., Trout, R., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 (1996), 1055–1060.
4. Kirksey, M., Chiu, Y.L., Ma, Y., Della Valle, A.G., Poultsides, L., Gerner, P., et al. Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008. Anesth Analg 115 (2012), 321–327.
5. Ponnusamy, K.E., Kim, T.J., Khanuja, H.S., Perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am 96 (2014), 1836–1844.
6. Okamoto, S.O.U., Amino-methyl-cyclohexane-carboxylic acid: AMCHA. A new potent inhibitor of fibrinolysis. Keio J Med 11 (1962), 105–115.
7. Okamoto, S.S.S., Takada, Y., Okamoto, U., An active stereo-isomer (Trans-Form) of amcha and its antifibrinolytic (antiplasminic) action in vitro and in vivo. Keio J Med 13 (1964), 177–185.
8. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151 (2009), 264–269 W64.
9. Wong, J., Abrishami, A., El Beheiry, H., Mahomed, N.N., Roderick Davey, J., Gandhi, R., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92 (2010), 2503–2513.
10. Gross, J.B., Estimating allowable blood loss: corrected for dilution. Anesthesiology 58 (1983), 277–280.
11. Nadler, S.B., Hidalgo, J.H., Bloch, T., Prediction of blood volume in normal human adults. Surgery 51 (1962), 224–232.
12. Dias, S., Welton, N.J., Caldwell, D.M., Ades, A.E., Checking consistency in mixed treatment comparison meta-analysis. Stat Med 29 (2010), 932–944.
13. Dias, S., Welton, N.J., Sutton, A.J., Ades, A.E., A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. 2014, NICE Decision Support Unit Technical Support Documents, London.
14. American Academy of Orthopaedic Surgeons. AAOS Clinical Practice Guideline and Systematic Review Methodology. version 2, https://www.aaos.org/uploadedFiles/PreProduction/Quality/Guidelines_and_Reviews/guidelines/Guideline%20and%20Systematic%20Review%20Processes_v2.0_Final.pdf.
15. Alshryda, S., Mason, J., Sarda, P., Nargol, A., Cooke, N., Ahmad, H., et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H) (Provisional abstract). J Bone Joint Surg Am 95 (2013), 1969–1974.
16. Barrachina, B., Lopez-Picado, A., Remon, M., Fondarella, A., Iriarte, I., Bastida, R., et al. Tranexamic acid compared with placebo for reducing total blood loss in hip replacement surgery: a randomized clinical trial. Anesth Analg 122 (2016), 986–995.
17. Benoni, G., Fredin, H., Knebel, R., Nilsson, P., Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 72 (2001), 442–448.
18. Benoni, G., Lethagen, S., Nilsson, P., Fredin, H., Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 71 (2000), 250–254.
19. Castro-Menendez, M., Pena-Paz, S., Rocha-Garcia, F., Rodriguez-Casas, N., Huici-Izco, R., Montero-Vieites, A., Rev Esp Cir Ortop Traumatol 60 (2016), 315–324.
20. Claeys, M., Vermeersch, N., Haentjens, P., Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 107 (2007), 397–401.
21. Ekback, G., Axelsson, K., Ryttberg, L., Edlund, B., Kjellberg, J., Weckstrom, J., et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 91 (2000), 1124–1130.
22. Emara, W.M., Moez, K.K., Elkhouly, A.H., Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesth Essays Res 8 (2014), 48–53.
23. Fraval, A., Effeney, P., Fiddelaers, L., Smith, B., Towell, B., Tran, P., et al. Outcome benefits of tranexamic acid in hip arthroplasty. A randomized double-blinded controlled trial. J Arthroplasty 32 (2017), 1516–1519.
24. Hourlier, H., Fennema, P., Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: a randomised clinical trial. Hip Int 24 (2014), 63–68.
25. Hsu, C., Lin, P., Kuo, F., Wang, J., A regime of two intravenous injections of tranexamic acid reduces blood loss in minimally invasive total hip arthroplasty: a prospective randomised double-blind study. Bone Joint J 97-B (2015), 905–910.
26. Husted, H., Blønd, L., Sonne-Holm, S., Holm, G., Jacobsen, T., Gebuhr, P., Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 74 (2003), 665–669.
27. Imai, N., Dohmae, Y., Suda, K., Miyasaka, D., Ito, T., Endo, N., Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty 27 (2012), 1838–1843.
28. Jaszczyk, M., Kozerawski, D., Kolodziej, L., Kazimierczak, A., Sarnecki, P., Sieczka, L., Effect of single preoperative dose of tranexamic acid on blood loss and transfusion in hip arthroplasty. Ortop Traumatol Rehabil 17 (2015), 265–273.
29. Johansson, T., Pettersson, L., Lisander, B., Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop 76 (2005), 314–319.
30. Kayupov, E., Fillingham, Y.A., Okroj, K., Plummer, D.R., Moric, M., Gerlinger, T.L., et al. Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 99 (2017), 373–378.
31. Kazemi, S., Mosaffa, F., Eajazi, A., Kaffashi, M., Besheli, L., Bigdeli, M., et al. Hip the effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics, 33, 2010, 17.
32. Lee, Y., Park, S., Kim, J., Cho, C., Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement. J Clin Anesth 25 (2013), 393–398.
33. Lemay, E., Guay, J., Cote, C., Roy, A., Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 51 (2004), 31–37.
34. Malhotra, R., Kumar, V., Garg, B., The use of tranexamic acid to reduce blood loss in primary cementless total hip arthroplasty. Eur J Orthop Surg Traumatol 21 (2011), 101–104.
35. Na, H., Shin, H., Lee, Y., Kim, J., Koo, K., Do, S., The effect of tranexamic acid on blood coagulation in total hip replacement arthroplasty: rotational thromboelastographic (ROTEM®) analysis. Anaesthesia 71 (2016), 67–75.
36. Niskanen, R., Korkala, O., Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop 76 (2005), 829–832.
37. North, W., Mehran, N., Davis, J., Silverton, C., Weir, R., Laker, M., Topical vs intravenous tranexamic acid in primary total hip arthroplasty: a double-blind, randomized controlled trial. J Arthroplasty 31 (2016), 1022–1026.
38. Oremus, K., Sostaric, S., Trkulja, V., Haspl, M., Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion 54 (2014), 31–41.
39. Rajesparan, K., Biant, L.C., Ahmad, M., Field, R.E., The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 91 (2009), 776–783.
40. Sadeghi, M., Mehr-Aein, A., Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Med Iran 45 (2007), 437–442.
41. Wang, C., Kang, P., Ma, J., Yue, C., Xie, J., Pei, F., Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: a double-blind, randomized controlled trial of different doses. Thromb Res 141 (2016), 119–123.
42. Wei, W., Wei, B., Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty 29 (2014), 2113–2116.
43. Xie, J., Ma, J., Yue, C., Kang, P., Pei, F., Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip Int 26 (2016), 36–42.
44. Xu, X., Li, X., Liu, W., Wang, Z., Longtime soaking of high concentration tranexamic acid in total hip arthroplasty: a prospective randomized controlled trial in 224 patients. Pakistan J Med Sci 31 (2015), 1306–1311.
45. Yamasaki, S., Masuhara, K., Fuji, T., Tranexamic acid reduces blood loss after cementless total hip arthroplasty - prospective randomized study in 40 cases. Int Orthop 28 (2004), 69–73.
46. Yi, Z., Bin, S., Jing, Y., Zongke, Z., Pengde, K., Fuxing, P., Tranexamic acid administration in primary total hip arthroplasty a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg Am 98 (2016), 983–991.
47. Yue, C., Kang, P., Yang, P., Xie, J., Pei, F., Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty 29 (2014), 2452–2456.
48. Zhang, Y., Cheng, T., Zhang, X., Impact of tranexamic acid and autologous blood transfusion on postoperative complications after primary total knee arthroplasty: a retrospective comparative study. Int J Clin Exp Med 9 (2016), 3842–3850.